Parvovirus B19 in Pregnancy: A Case Review

Area of Science:

• Virology
• Obstetrics
• Maternal-Fetal Medicine

Background:

• Parvovirus B19 causes erythema infectiosum (fifth disease), a common childhood illness highly contagious in school settings.
• While most adults are immune, 40% of childbearing-age individuals remain susceptible.
• Infection during pregnancy, particularly the second trimester, poses significant risks to fetal development.

Purpose of the Study:

• To highlight the risks of Parvovirus B19 infection in pregnancy.
• To outline diagnostic and monitoring strategies for parvovirus B19 in pregnant individuals.
• To emphasize the importance of maternal-fetal medicine consultation for affected pregnancies.

Main Methods:

• Serum antibody screening (immunoglobulin G and M) for suspected parvovirus B19 infection.
• Serial ultrasound imaging (8-12 weeks) with Doppler assessment of middle cerebral artery peak systolic velocity for fetal monitoring.
• Referral for fetal blood sampling and intrauterine transfusion if hydrops fetalis or severe fetal anemia is suspected.

Main Results:

• Parvovirus B19 infection in pregnancy can lead to vertical transmission, severe fetal anemia, and hydrops fetalis.
• Fetal loss rates range from 8% to 17% in cases of severe fetal complications.
• Adults may present asymptomatically or with atypical symptoms like arthralgias, complicating early diagnosis.

Conclusions:

• Maternal history of exposure or atypical symptoms warrants prompt serum antibody screening for parvovirus B19.
• Positive immunoglobulin M results necessitate ongoing fetal surveillance via serial ultrasounds and Doppler studies.
• Management requires specialized care from maternal-fetal medicine experts to mitigate fetal risks.